Wednesday, June 7, 2023
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Professor of Medicine and Nutritional Sciences
University of Toronto
Division of Endocrinology and Metabolism
St. Michael's Hospital
Toronto, Ontario, Canada
Professor of Internal Medicine (chair)
University of Helsinki
Chief Physician
Helsinki University Hospital
Helsinki, Finland
Clinical Professor
Department of Medicine
University of Washington School of Medicine
Providence Medical Research Center
Providence Health Care
Spokane and Seattle, Washington, United States
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Non-US Physicians - maximum of 0.50 CPD
This educational activity is intended for an international audience of non-US primary care physicians, diabetologists/endocrinologists, and nephrologists. (Excluding UK and Ireland)
The goal of this activity is for learners to be better able to recognize the importance of early chronic kidney disease (CKD) detection, not only in patients with diabetes, as well as the benefits and practical use of reno-protective therapies like sodium-glucose cotransporter 2 (SGLT2) inhibitors in CKD management.
Upon completion of this activity, participants will:
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Professor of Medicine and Nutritional Sciences
University of Toronto
Division of Endocrinology and Metabolism
St. Michael's Hospital
Toronto, Ontario, Canada
Professor of Internal Medicine (chair)
University of Helsinki
Chief Physician
Helsinki University Hospital
Helsinki, Finland
Clinical Professor
Department of Medicine
University of Washington School of Medicine
Providence Medical Research Center
Providence Health Care
Spokane and Seattle, Washington, United States
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim
credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online
during the credit
eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied
in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well
as the certificates by
accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 3/14/2023
Valid for credit through: 3/14/2024
processing....
The goal of this activity is for learners to be better able to recognize the importance of early chronic kidney disease (CKD) detection, not only in patients with diabetes, as well as the benefits and practical use of reno-protective therapies like sodium-glucose cotransporter 2 (SGLT2) inhibitors in CKD management.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
